Predicting Chest Wall Pain From Lung Stereotactic Body Radiotherapy for Different Fractionation Schemes

被引:43
|
作者
Woody, Neil M. [1 ]
Videtic, Gregory M. M. [1 ]
Stephans, Kevin L. [1 ]
Djemil, Toufik [1 ]
Kim, Yongbok [2 ]
Xia, Ping [1 ]
机构
[1] Cleveland Clin, Dept Radiat Oncol, Taussig Canc Ctr, Cleveland, OH 44195 USA
[2] Allegheny Gen Hosp, Dept Radiat Oncol, Pittsburgh, PA 15212 USA
关键词
Stereotactic body radiation therapy; Chest wall pain; Modified effective uniform dose; Stage I lung cancer; Radiobiologic effect; RADIATION-THERAPY; CANCER; TRIAL;
D O I
10.1016/j.ijrobp.2011.06.1971
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Recent studies with two fractionation schemes predicted that the volume of chest wall receiving >30 Gy (V30) correlated with chest wall pain after stereotactic body radiation therapy (SBRT) to the lung. This study developed a predictive model of chest wall pain incorporating radiobiologic effects, using clinical data from four distinct SBRT fractionation schemes. Methods and Materials: 102 SBRT patients were treated with four different fractionations: 60 Gy in three fractions, 50 Gy in five fractions, 48 Gy in four fractions, and 50 Gy in 10 fractions. To account for radiobiologic effects, a modified equivalent uniform dose (mEUD) model calculated the dose to the chest wall with volume weighting. For comparison, V30 and maximum point dose were also reported. Using univariable logistic regression, the association of radiation dose and clinical variables with chest wall pain was assessed by uncertainty coefficient (U) and C statistic (C) of receiver operator curve. The significant associations from the univariable model were verified with a multivariable model. Results: 106 lesions in 102 patients with a mean age of 72 were included, with a mean of 25.5 (range, 12-55) months of follow-up. Twenty patients reported chest wall pain at a mean time of 8.1 (95% confidence interval, 6.3-9.8) months after treatment. The mEUD models, V30, and maximum point dose were significant predictors of chest wall pain (p < 0.0005). mEUD improved prediction of chest wall pain compared with V30 (C = 0.79 vs. 0.77 and U = 0.16 vs. 0.11). The mEUD with moderate weighting (a = 5) better predicted chest wall pain than did mEUD without weighting (a = 1) (C = 0.79 vs. 0.77 and U = 0.16 vs. 0.14). Body mass index (BMI) was significantly associated with chest wall pain (p = 0.008). On multivariable analysis, mEUD and BMI remained significant predictors of chest wall pain (p = 0.0003 and 0.03, respectively). Conclusion: mEUD with moderate weighting better predicted chest wall pain than did V30, indicating that a small chest wall volume receiving a high radiation dose is responsible for chest wall pain. Independently of dose to the chest wall, BMI also correlated with chest wall pain. (C) 2012 Elsevier Inc.
引用
收藏
页码:427 / 434
页数:8
相关论文
共 50 条
  • [1] Chest Wall Toxicity from Lung Stereotactic Body Radiotherapy (SBRT): A Dosimetric Analysis using Several Fractionation Schemes
    Stephans, K.
    Woody, N. M.
    Videtic, G. M. M.
    Djemil, T.
    Xia, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S506 - S506
  • [2] Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy
    Creach, Kimberly M.
    El Naqa, Issam
    Bradley, Jeffrey D.
    Olsen, Jeffrey R.
    Parikh, Parag J.
    Drzymala, Robert E.
    Bloch, Charles
    Robinson, Clifford G.
    RADIOTHERAPY AND ONCOLOGY, 2012, 104 (01) : 23 - 27
  • [3] Dosimetric Variables for Chest Wall Pain following Lung Stereotactic Body Radiotherapy
    Pembroke, C.
    Albers, J.
    Kildea, J.
    Parker, W.
    Faria, S.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S767 - S767
  • [4] PREDICTION OF CHEST WALL TOXICITY FROM LUNG STEREOTACTIC BODY RADIOTHERAPY (SBRT)
    Stephans, Kevin L.
    Djemil, Toufik
    Tendulkar, Rahul D.
    Robinson, Cliff G.
    Reddy, Chandana A.
    Videtic, Gregory M. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (02): : 974 - 980
  • [5] Spatiotemporal fractionation schemes for liver stereotactic body radiotherapy
    Unkelbach, Jan
    Papp, David
    Gaddy, Melissa R.
    Andratschke, Nicolaus
    Hong, Theodore
    Guckenberger, Matthias
    RADIOTHERAPY AND ONCOLOGY, 2017, 125 (02) : 357 - 364
  • [6] Spatiotemporal fractionation schemes for liver stereotactic body radiotherapy
    Unkelbach, J.
    Papp, D.
    Gaddy, M.
    Andratschke, N.
    Hong, T.
    Guckenberger, M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S479 - S480
  • [7] Prediction of Chest Wall Toxicity after Lung Stereotactic Body Radiotherapy (SBRT)
    Stephans, K.
    Djemil, T.
    Tendulkar, R.
    Robinson, C.
    Reddy, C.
    Videtic, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S60 - S60
  • [8] Predictors and management of chest wall toxicity after lung stereotactic body radiotherapy
    Shaikh, Talha
    Turaka, Aruna
    CANCER TREATMENT REVIEWS, 2014, 40 (10) : 1215 - 1220
  • [9] Dosimetric Risk Estimation of Chest Wall Pain Following 5-Fraction Lung Stereotactic Body Radiotherapy
    Rummel, K. A.
    Johnson, L.
    Price, A. O.
    Wilson, J. S.
    Watkins, P. L.
    Rogstad, C. A.
    Gray, T.
    Watkins, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E51 - E52
  • [10] CHEST WALL TOXICITY AFTER STEREOTACTIC BODY RADIOTHERAPY FOR MALIGNANT LESIONS OF THE LUNG AND LIVER
    Andolino, David L.
    Forquer, Jeffrey A.
    Henderson, Mark A.
    Barriger, Robert B.
    Shapiro, Ronald H.
    Brabham, Jeffrey G.
    Johnstone, Peter A. S.
    Cardenes, Higina R.
    Fakiris, Achilles J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (03): : 692 - 697